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Abstract
Aims/hypothesis O-GlcNAcylation plays a role as a metabolic
sensor regulating cellular signalling, transcription and metab-
olism. Transcription factors and signalling pathways related to
metabolism are modulated by N-acetyl-glucosamine (O-
GlcNAc) modification. Aberrant regulation of O-
GlcNAcylation is closely linked to insulin resistance, type 2
diabetes and obesity. Current evidence shows that increased
O-GlcNAcylation negatively regulates insulin signalling,
which is associated with insulin resistance and type 2 diabetes.
Here, we aimed to evaluate the effects of Oga (also known as
Mgea5) haploinsufficiency, which causes hyper-O-
GlcNAcylation, on metabolism.
Methods We examined whether Oga+/- mice developed insu-
lin resistance. Metabolic variables were determined including
bodyweight, glucose and insulin tolerance, metabolic rate and
thermogenesis.
Results Oga deficiency does not affect insulin signalling even
at hyper-O-GlcNAc levels. Oga+/- mice are lean with reduced
fat mass and improved glucose tolerance. Furthermore,Oga+/-
mice resist high-fat diet-induced obesity with ameliorated he-
patic steatosis and improved glucose metabolism. Oga
haploinsufficiency potentiates energy expenditure through
the enhancement of brown adipocyte differentiation from the
stromal vascular fraction of subcutaneous white adipose tissue
(WAT).
Conclusions/interpretation Our observations suggest that
O-GlcNAcase (OGA) is essential for energy metabolism via
regulation of the thermogenic WAT program.
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Introduction
O-GlcNAcylation is an endpoint in the hexosamine biosyn-
thetic pathway, which produces UDP-N-acetyl-glucosamine
(UDP-GlcNAc), a donor substrate for O-GlcNAc transferase
(OGT). Production of UDP-GlcNAc is influenced by the me-
tabolism of carbohydrates, amino acids, fats and nucleotides.
O-GlcNAcylation modulates diverse cellular processes in re-
sponse to nutrients. Thus, aberrantO-GlcNAcylation has been
implicated in many chronic diseases, such as diabetes, obesity,
neurodegeneration and cancer [1]. Many studies show that
insulin signalling is negatively regulated by the O-
GlcNAcylation of proteins involved in the insulin signalling
pathway [2, 3]. O-GlcNAcylation regulates the activity of
transcription factors and cofactors that play key roles in me-
tabolism. Peroxisome proliferator-activated receptor γ
coactivator-1-α (PGC1α), CREB-regulated transcription co-
activator 2 (CRTC2), forkhead box protein O1 (FOXO1),
carbohydrate-responsive element-binding protein (ChREBP)
and liver X receptor α (LXRα) are O-GlcNAcylated, and
modification of these proteins regulates gluconeogenic/
lipogenic genes by modulating transcriptional activity in
the liver [4–7]. Importantly, the genetic variation in the
O-GlcNAase (Oga, also known as Mgea5) gene contrib-
utes to increased risk for type 2 diabetes [8]. However,
in some populations, Oga is not significantly associated
with type 2 diabetes [9].
Mammals have two different types of adipose tissue, white
(WAT) and brown adipose tissue (BAT). WAT is the primary
site of energy storage, while BAT is a thermogenic tissue.
Current evidence shows that environmental conditions induce
the development of brown-like adipocytes, the so called beige
adipocytes, within certain WAT depots. How the white-to-
brown fat transition is regulated is an important issue, as ther-
mogenesis plays a significant role in regulating body weight
and protects against diabetes and obesity [10]. In this study,
we focused on the role ofO-GlcNAcase (OGA) in controlling
energy expenditure and evaluated the effects of Oga
haploinsufficiency in a mouse model.
Methods
Mice Oga+/- mice (C57BL/SV129) were generated as de-
scribed previously [11] and maintained on the C57BL/6J ge-
netic background; C57BL/6J breeders were purchased from
Jackson Laboratory (Bar Harbor, ME, USA). Mouse strains
were bred and housed in the Animal Research Facility at
Ulsan National Institute of Science and Technology
(UNIST) under specific pathogen-free conditions. Standard
chow (A03, Scientific Animal Food & Engineering, Augy,
France) or a high-fat diet (HFD; 60% of the energy content
from fat, D12492; Research Diets, New Brunswick, NJ, USA)
and water were provided ad libitum. Experiments were per-
formed after mice were genotyped, without randomisation or
blinding. No data were specifically included or excluded. The
Institutional Animal Care and Utilization Committee ap-
proved all procedures, in accordance with the UNIST Guide
for the Care and Use of Laboratory Animals.
Metabolic analysis Body weight was measured weekly, and
body composition was assessed using a quantitative nuclear
magnetic resonance (NMR) system (EchoMRI100V, Echo
Medical Systems, Houston, TX, USA). Oxygen consumption,
carbon dioxide production and food intake were measured
using Comprehensive Lab Animal Monitoring System
(CLAMS; Columbus Instruments, Columbus, OH, USA).
For the glucose tolerance test (GTT), mice were given an
i.p. injection of D-glucose (1 g/kg bodyweight) after overnight
starvation. For the insulin tolerance test (ITT), mice were
fasted for 6 h and injected with human insulin (0.75 U/kg
body weight). Serum glucose levels were determined in tail
blood samples using a glucometer (Accu-Check Active,
Roche, Mannheim, Germany). The serum levels of insulin
and leptin were assessed using ELISA kits (Shibayagi,
Shibayagi, Gunma, Japan), and triacylglycerol (TG) levels
were determined using a colorimetric assay (Cayman
Chemical, Ann Arbor, MI, USA). Body temperatures were
measured rectally using a digital thermometer (TD-300,
Shibaura Electronics, Tokyo, Japan).
Preparation and adipocyte differentiation of stromal vas-
cular fraction cells Stromal vascular fraction (SVF) cells
were isolated from the inguinal adipose tissue of 5–6-week-
old mice. Inguinal adipose tissue was excised and minced in
10 ml digestion buffer (100 mmol/l HEPES pH7.4, 120
mmol/l NaCl, 50 mmol/l KCl, 5 mmol/l glucose, 1 mmol/l
CaCl2, 1.5% BSA-fatty acid free and 1 mg/ml collagenase
II), and the tissue was incubated at 37°C with shaking for
2 h. Larger particles were removed using a 100 μm cell
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strainer, and 30 ml SVF medium (DMEM/F12 [1:1], 10%
FBS, Glutamax and Pen/Strep) was added to filtrates. The
filtrates were centrifuged at 600g for 5 min to remove floating
adipocytes. The pelleted SVF cells were resuspended in 10 ml
SVF medium and passed through a 40-μm cell strainer.
Adipocyte differentiation of confluent SVF cells was induced
after 2 days using 5 μg/ml insulin, 5 μmol/l 3-isobutyl-1-
methylxanthine, 5 μmol/l dexamethasone, 1 nmol/l 3,3′,5-
triiodo-L-thyronine, 125 μmol/l indometacin and 1 μmol/l
rosiglitazone. The cells were kept in differentiation medium
containing 5 μg/ml insulin, 1 nmol/l 3,3′,5-triiodo-L-thyronine
and 1 μmol/l rosiglitazone for an additional 6 days. The
medium was changed every 2 days.
Adipocyte differentiation of mouse embryo fibroblasts
Mouse embryo fibroblasts (MEFs) were harvested from
12.5–14.5 days post coitum embryos as described previously
[11]. MEFs were propagated to confluence. Two days later,
adipocyte differentiation was induced by treatment with
5 μg/ml insulin, 5 μmol/l 3-isobutyl-1-methylxanthine,
5 μmol/l dexamethasone and 125 μmol/l indometacin. This
medium was changed every other day. After 4 days, the in-
duction medium containing 5 μg/ml insulin was used to main-
tain differentiation.
Western blotting Tissue and cell lysates were prepared using
standard procedures. Protein samples (20–30 μg) were sepa-
rated on an SDS-polyacrylamide gel and visualised. The anti-
bodies used are listed in Electronic Supplementary Material
(ESM) Methods.
Real-time PCR analysis Real-time PCR analysis and the
primers used are listed in ESM Methods and in ESM Table 1.
Statistical analysis Data are presented as the mean ± SEM or
SD as indicated in the figure legends. Comparisons between
two groups were performed using unpaired two-tailed
Student's t tests. A p value <0.05 was considered statistically
significant.
Results
IncreasedO-GlcNAcylation has no effect on insulin signal-
ling Many studies show that increased O-GlcNAcylation by
OGT overexpression or O-(2-acetamido-2-deoxy-D-
glucopyranosylidene) amino-N-phenylcarbamate (PUGNAc)
treatment perturbs activation of insulin signalling. To investi-
gate whether elevated O-GlcNAcylation by Oga deletion af-
fects insulin signalling, we treated Oga+/+ and Oga-/- MEFs
with insulin. Phosphorylation of IRS-1 at Tyr608 and of Akt at
Thr308/Ser473 triggered by insulin was not perturbed inOga-/-
MEFs with high levels of O-GlcNAcylation (Fig. 1a). To
further confirm the effect of increased O-GlcNAcylation on
insulin signalling, we used Oga+/- mice. We previously report-
ed neonatal lethality inOga-/- mice [11]. However,Oga+/- mice
are viable and fertile, and western blot analysis showed in-
creased O-GlcNAcylation in metabolic tissues, liver, muscle,
andWAT inOga+/- mice compared withOga+/+ mice (Fig. 1b).
Oga+/+ and Oga+/- mice were starved and injected i.p. with
insulin. Insulin-stimulated Akt phosphorylation in the liver,
muscle and WAT of Oga+/- mice was not suppressed by in-
creased O-GlcNAcylation signalling (Fig. 1c).
Oga+/- mice have a lean phenotype and reduced fat mass
Oga+/- mice were apparently smaller than Oga+/+ mice
throughout development after birth. Oga+/- mice fed normal
chow (NC) showed significant decreases in body weight
resulting in a lean phenotype (Fig. 2a). Importantly, the per-
centage of fat mass in Oga+/+ mice was significantly reduced,
whereas lean mass was comparable between Oga+/+ and
Oga+/- mice (Fig. 2b). Weights of BAT in Oga+/- mice were
unchanged compared with OGA+/+ mice. Lipid content of
perigonadal (PG) WAT appeared to be slightly lower in
Oga+/- mice than Oga+/+ mice, but the difference was not
significant. In contrast, lipid content in inguinal subcutaneous
(SC)WATwas reduced inOga+/- mice (Fig. 2c). There was no
significant difference in cell size in the BAT and PG WAT
between Oga+/+ and Oga+/- mice. Notably, the SC WAT of
Oga+/- mice showed islets of multilocular brown fat-like adi-
pocytes (Fig. 2d).
Previous data show that increasedO-GlcNAcylation due to an
OGA i n h i b i t o r , 1 , 2 - d i d e o x y - 2 0 - p r o p y l -α - D -
glucopyranoso-[2,1-d]-δ 20-thiazoline (NButGT), suppresses
adipocyte differentiation through modulation of PPARγ tran-
scriptional activity [12]. To assess whether the reduced WAT
weight in Oga+/- mice results from a decrease in adipocyte
number due to impaired differentiation, we compared the ad-
ipocyte differentiation capacity of MEFs isolated fromOga+/+
and Oga-/- embryos. After undergoing differentiation into ad-
ipocytes, we observed no differences in accumulation of in-
tracellular lipids as determined using Oil Red O staining
(Fig. 2e,f). This result suggests that the reduced WAT weight
of Oga+/- mice does not reflect impaired adipogenesis of pre-
cursor cells.
Improved glucose tolerance in Oga+/- mice We next inves-
tigated whetherOga heterozygosity affects glucose homeosta-
sis. No changes in blood glucose level, serum insulin level, or
serum leptin were observed betweenOga+/+ andOgaA+/- mice
under fasting conditions (Fig. 3a–c). The GTT showed that
glucose levels in Oga+/- mice remained significantly lower
than those of control Oga+/+ mice after glucose injection, in-
dicating that glucose tolerance was better in Oga+/- mice than
Oga+/+ mice (Fig. 3d). In contrast, no difference was observed
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in insulin sensitivity between Oga+/+ and Oga+/- mice as mea-
sured by the ITT, indicating that hepatic insulin sensitivity was
unaffected in Oga+/- mice (Fig. 3e). To determine whether
Oga heterozygosity affects gluconeogenesis and lipid metab-
olism, we measured the mRNA expression of key
gluconeogenic (Pepck [also known as Pck1], G6p [also
known as H6pd] and Pgc1α [also known as Ppargc1a]) and
fatty acid metabolism-related genes (Fasn, Mcad [also known
as Acadm], Scd1 and Srebp-1c [also known as Srebf1]).
Notably, mRNA levels of hepatic Pepck and G6p were
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reduced in Oga+/- mice compared with Oga+/+ mice. In con-
trast, Pgc1α levels were not altered in Oga+/- mice. These
results indicate that improved glucose tolerance is reflected
by reduced expression of gluconeogenesis genes in Oga+/-
mice. With regard to fatty acid metabolism, no significant
difference was observed between Oga+/+ and Oga+/- mice
(Fig. 3f).
Increased energy expenditure in Oga+/- mice Body weight
is determined by the balance between food intake and energy
expenditure. Therefore, we speculated that energy expenditure
might be elevated in Oga+/- mice compared with Oga+/+
mice. Nutrients were burned more efficiently in Oga+/-
mice than in Oga+/+ mice. Increased body oxygen con-
sumption (Fig. 4a,b) and CO2 production (Fig. 4c,d)
were observed in Oga+/- mice during dark and light
periods compared with Oga+/+ mice. The rate of food
intake per day was not significantly different between
Oga+/+ and Oga+/- mice (Fig. 4e). The increased meta-
bolic rate was not due to increased physical activity
(Fig. 4f,g). Heat production was not significantly altered
in Oga+/- mice compared with wild-type mice (Fig. 4h).
Several studies suggested that elevation ofO-GlcNAcylation
enhances fatty acid oxidation through activation of AMP-
activated protein kinase (AMPK), a key player regulating energy
balance at both the cellular and whole-body levels [13, 14]. We
examined the phosphorylation of AMPK and acetyl-CoA car-
boxylase (ACC) in muscle, liver andWAT isolated fromOga+/+
and Oga+/- mice. There were no significant differences in phos-
phorylation of AMPK or ACC (ESM Fig. 1).
Oga+/- mice were resistant to HFD-induced obesity and
showed improved glucose tolerance and insulin sensitivity
To examine the effects of Oga heterozygosity on HFD-
induced obesity and insulin resistance, we challenged Oga+/-
mice with a HFD for 12 weeks. On the HFD, Oga+/+ mice
became obese, whereas Oga+/- mice were quite resistant to
obesity. Body weight accumulation was lower in Oga+/- mice
than inOga+/+ mice (Fig. 5a). The fat mass ofOga+/- mice fed
a HFD was significantly smaller than that of Oga+/+ mice
(Fig. 5b). Notably, the weights of SC WAT, PG WAT and
BAT of Oga+/- mice were lower than those of Oga+/+ mice.
The weight of PG WAT in Oga+/- mice was slightly reduced
compared with Oga+/+ mice, but the difference was not sig-
nificant (Fig. 5c). Histological analysis revealed no significant
differences in white adipocyte size between Oga+/+ mice and
Oga+/- mice. In contrast, Oga+/- mice showed reduced lipid
accumulation in BAT and liver compared with Oga+/+ mice.
Moreover, haematoxylin and eosin staining and Oil Red O
staining revealed that liver steatosis was much lower in
Oga+/- mice than Oga+/+ mice (Fig. 5d). Consistent with the
lean phenotype, blood glucose, serum TG, insulin and leptin
levels in Oga+/- mice were significantly reduced relative to
Oga+/+ mice during the HFD feeding period (Fig. 5e, ESM
Fig. 2a–c). We next assessed glucose homeostasis and insulin
sensitivity. Oga+/- mice showed improved glucose tolerance
and increased insulin sensitivity compared with Oga+/+ mice
on a HFD (Fig. 5f and 5g). To determine whether Oga+/-
mice fed a HFD also exhibited increased energy expen-
diture, we monitored the metabolic activities of these
mice using CLAMS. Oga+/- mice displayed increased
oxygen consumption (Fig. 5h,i) and CO2 production
(ESM Fig. 3a,b) on the HFD. Food intake did not sig-
nificantly differ between Oga+/+ mice and Oga+/- mice
(ESM Fig. 3c). Despite the increased energy expenditure,
locomotor activity was decreased in Oga+/- mice (ESM
Fig. 3d,e). Heat production was slightly, but not signifi-
cantly, increased in Oga+/- mice (ESM Fig. 3f).
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Enhanced differentiation of subcutaneous WAT-derived
SVF cells into brown-like adipocytes in Oga+/- mice To
determine the relative levels of O-GlcNAc cycling enzymes
and O-GlcNAcylation levels in BAT and WATs, we isolated
BAT, PG and SC WAT from wild-type mice. OGT and OGA
expression levels were higher in SCWAT than in BATand PG
WAT, and the levels ofO-GlcNAcylation were elevated in PG
WAT and SCWAT compared with BAT (Fig. 6a). The weight
(Fig. 2c) and histological morphology of BAT (Fig. 2d) did
not differ between Oga+/+ mice and Oga+/- mice. Notably, the
weight of SC WAT in Oga+/- mice was lower than that in
Oga+/+ mice (Fig. 2c). In addition, SC WAT in Oga+/- mice
contained clusters of brown-like adipocytes (multilocular ad-
ipocytes), also known as beige fat cells (Fig. 2d). The thermo-
genic gene program of beige fat cells elevates energy expen-
diture leading to body weight loss [10]. The thermogenic
genes were significantly increased in SC WAT in Oga+/- mice
(Fig. 6b). In PG WAT, Pgc1a and Elovl3 expression levels
were elevated in Oga+/- mice compared with Oga+/+ mice
(Fig. 6c). However, there was no significant difference in
BAT between Oga+/+ and Oga+/- mice (Fig. 6d).
To investigate the function of OGA in the thermogenic
adaptation of SC WAT, we exposed wild-type mice to cold
temperatures. The OGA protein was decreased in the SCWAT
of cold-exposedmice concomitant with increased PGC1α and
uncoupling protein 1 (UCP1) proteins, while OGT protein
was not significantly altered, suggesting an important role
for OGA in thermogenic adaptation (Fig. 6e). To assess the
effect of Oga haploinsufficiency in thermogenesis, we chal-
lenged Oga+/+ and Oga+/- mice using cold temperatures.
Although core body temperature did not differ between
Oga+/+ andOga+/- mice at 23°C,Oga+/- mice had higher body
temperatures than those of Oga+/+ mice at 4°C (Fig. 6f).
Consistent with these results, PGC1α and UCP1 expression
levels in SC WAT of Oga+/- mice are markedly increased
compared with Oga+/+ mice (Fig. 6g).
The SVF contains fat progenitor cells that have the poten-
tial to differentiate into brown-like adipocytes [10, 15]. This
prompted us to examine whether the differentiation of SVF
from SC WAT into brown-like adipocytes is enhanced in
Oga+/- mice. We isolated SVF from SC WAT of Oga+/+ and
Oga+/- mice, followed by induction of adipocyte differentia-
tion. Both groups of SVF efficiently differentiated into adipo-
cytes, as indicated by Oil Red O staining (Fig. 6h). Notably,
brown-like adipocyte genes—Pgc1a, Ucp1, Cidea and
Cox5b—were significantly increased in the differentiated
Oga+/- SVF compared with Oga+/+ SVF (Fig. 6i,j). To evalu-
ate the effects of increased O-GlcNAcylation on the differen-
tiation of SVF, adipose SVF cells were treated with Thiamet-G,
a potent and selective OGA inhibitor [16]. However,
ThiametG treatment did not affect brown adipocyte dif-
ferentiation of SVF cells (ESM Fig. 4a). Notably, in-
creased O-GlcNAcylation by Thiamet-G treatment re-
sulted in elevated OGA expression (ESM Fig. 4b), as
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previously observed [17]. These results indicate that the
control of OGA protein expression is required for dif-
ferentiation of SVF.
To further observe synergistic effects, we evaluated differ-
entiated SVF in the presence of forskolin, an adenylyl cyclase
activator. Activation of cAMP triggers protein kinase A
(PKA) activation, which induces the expression of thermo-
genic genes [18]. mRNA levels of Pgc1a and Cox5b were
markedly elevated in the differentiated Oga+/- SVF compared
with Oga+/+ SVF (Fig. 6k). Overall, these results suggest that
Oga heterozygosity enhances brown adipocyte differentiation
of SVF from SC WAT.
Discussion
In this study, we demonstrated the important role of OGA in
controlling energy expenditure in vivo using Oga+/- mice.
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Importantly, we observed that increased O-GlcNAcylation
does not affect insulin signalling. Oga+/- mice are lean, with
reduced body fat mass and resistance to diet-induced obesity,
which results from enhanced brown adipocyte differentiation
in SC WAT. Our findings thus provide novel insight in to the
role of OGA in thermogenesis.
We found that increasedO-GlcNAcylation through genetic
deletion of Oga does not affect insulin signalling or lead to
insulin resistance. However, accumulating evidence suggests
that increased O-GlcNAcylation leads to insulin resistance by
negatively regulating insulin signalling. Elevation of O-
GlcNAcylation by PUGNAc (an OGA inhibitor) suppresses
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insulin signalling in cultured cells [19]. In addition to results
from in vitro studies, researchers found that increased levels of
O-GlcNAcylation lead to insulin resistance in vivo [2, 20].
PUGNAc is a potent inhibitor of OGA; however, it has some
off-target effects [21, 22]. Several papers show that other
OGA inhibitors, such as NButGT, do not affect insulin signal-
ling [23, 24]. Moreover, NButGTalso does not disturb insulin
signalling in vivo [25]. These complex results were also
observed in nuclear factor κB (NF-κB) [26, 27] and Wnt
signalling [17, 28]. The different effects of the changes in
O-GlcNAc levels might result from the different methods used
to elevate O-GlcNAcylation.
We found thatOga haploinsufficiency enhances brown ad-
ipocyte differentiation in WAT SVF. Many factors that regu-
late brown adipocyte differentiation, such as PGC1α [29],
PPARγ [30] and β-catenin [31], have been identified.
Importantly, these factors were O-GlcNAcylated [12, 32,
33]. Thus, we speculate that the increased brown adipocyte
differentiation in Oga+/- mice might be due to the altered ac-
tivity of key factors that are O-GlcNAcylated or form com-
plexes with O-GlcNAc cycling enzymes.
Recently, the phenotype of different Oga+/- mice lines was
analysed [34]. Keembiyehetty et al generated Oga knockout
mice by crossing floxed Oga mice with murine mammary
tumour virus (MMTV)-Cre mice, which express Cre
recombinase in the murine zygote. We used Oga+/+ and
Oga+/- male mice in all experiments. Oga+/- female mice also
had significantly lower body weight than Oga+/+ female mice
(ESM Fig. 5). In contrast, Keembiyehetty et al observed dif-
ferent results, showing that the body weight of Oga+/+ and
Oga+/- male mice were comparable, whereas Oga+/- female
mice showed increased weight gain compared with Oga+/+
mice on NC and high-fat chow. As Keembiyehetty et al re-
ported increased respiratory exchange ratio (RER) in Oga+/-
female mice, we also observed elevated RER in Oga+/- mice
compared with Oga+/+ mice (ESM Fig. 6). These results indi-
cate that Oga+/- mice utilise more carbohydrates than do
Oga+/+ mice. Notably, Oga deficient mice generated by gene
trap exhibited increased levels of O-GlcNAcylation and re-
duced OGT protein expression [11], which is consistent with
the current hypothesis ofO-GlcNAc homeostasis [35]. In con-
trast, both OGT protein expression and O-GlcNAcylation
levels were elevated in OGA heterozygous mice produced
by conditional disruption. We speculate that the different gene
knock-out methods might lead to the different molecular and
physiological changes in the two lines of Oga heterozygous
mice.
Ruan et al demonstrated that OGT in agouti-related peptide
(AgRP) neurons regulate browning of WAT through modula-
tion of O-GlcNAcylation of Kv channels [36]. They used
AgRP neuron-specific Ogt-deleted mice. Decreased O-
GlcNAcylation of Kv channels impairs neuronal firing in
AgRP-Ogt knockout mice, which promotes browning of
WAT and protects against diet-induced obesity. In contrast,
we suggest that Oga heterozygosity intrinsically enhances
brown adipocyte differentiation in Oga+/- mice. However,
we could not exclude the possibility that abnormally elevated
O-GlcNAcylation in Oga+/- AgRP neurons also disrupts neu-
ronal firing, which contributes to browning of white fat in
Oga+/- mice. This hypothesis is supported by many studies
showing that a number of proteins involved in neuronal sig-
nalling and synaptic function are O-GlcNAcylated [37].
Consistent with this evidence, increased O-GlcNAcylation
impairs synaptic function [38, 39]. Further electrophysiologi-
cal analysis using Oga+/- mice will be needed to test the
hypothesis.
Understanding the mechanisms controlling thermogenesis
is important for the prevention of weight gain and for under-
standing the development of obesity. Our results demonstrate
that the reduced body weight of Oga+/- mice results from
increased energy expenditure through enhanced brown adipo-
cyte differentiation in subcutaneous WAT. Based on our ob-
servations, changes in energy expenditure through the modu-
lation ofO-GlcNAc cycling may serve as a treatment for obe-
sity and the metabolic syndrome.
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